Company / Capital Expenditures
PUMA BIOTECHNOLOGY, INC. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$140.0K
FY2025
5-year range
$0 / $306.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0 to $140,000 over the past 2 years.
Based on SEC 10-K filings.
$140,000 in FY2025 with a 5-year CAGR of -3.8%.
Improved from $0 to $140,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +44.9%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.8%, indicating a declining trend.
- Peak capital expenditures was recorded in FY2018.
- Lowest capital expenditures in the period was in FY2024.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $140.0K | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $46.0K | -85.0% |
| FY2021 | $306.0K | +80.0% |
| FY2020 | $170.0K | +0.0% |
| FY2019 | $170.0K | -96.0% |
| FY2018 | $4.3M | +327.8% |
| FY2017 | $1.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026